LNTH
Price
$72.93
Change
+$2.00 (+2.82%)
Updated
Jul 25 closing price
Capitalization
4.27B
10 days until earnings call
ZTS
Price
$152.12
Change
-$0.70 (-0.46%)
Updated
Jul 25 closing price
Capitalization
77.48B
9 days until earnings call
Interact to see
Advertisement

LNTH vs ZTS

Header iconLNTH vs ZTS Comparison
Open Charts LNTH vs ZTSBanner chart's image
Lantheus Holdings
Price$72.93
Change+$2.00 (+2.82%)
Volume$615.57K
Capitalization4.27B
ZOETIS
Price$152.12
Change-$0.70 (-0.46%)
Volume$3.33M
Capitalization77.48B
LNTH vs ZTS Comparison Chart in %
Loading...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LNTH vs. ZTS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LNTH is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (LNTH: $72.93 vs. ZTS: $152.12)
Brand notoriety: LNTH: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LNTH: 59% vs. ZTS: 114%
Market capitalization -- LNTH: $4.27B vs. ZTS: $77.48B
LNTH [@Pharmaceuticals: Other] is valued at $4.27B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LNTH’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • LNTH’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, LNTH is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LNTH’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • LNTH’s TA Score: 4 bullish, 5 bearish.
  • ZTS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than LNTH.

Price Growth

LNTH (@Pharmaceuticals: Other) experienced а +3.92% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

LNTH is expected to report earnings on Aug 06, 2025.

ZTS is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than LNTH($4.27B). ZTS has higher P/E ratio than LNTH: ZTS (32.94) vs LNTH (12.93). ZTS YTD gains are higher at: -5.722 vs. LNTH (-18.478). ZTS has higher annual earnings (EBITDA): 3.67B vs. LNTH (491M). ZTS has more cash in the bank: 2.04B vs. LNTH (714M). LNTH has less debt than ZTS: LNTH (617M) vs ZTS (6.76B). ZTS has higher revenues than LNTH: ZTS (8.54B) vs LNTH (1.3B).
LNTHZTSLNTH / ZTS
Capitalization4.27B77.5B6%
EBITDA491M3.67B13%
Gain YTD-18.478-5.722323%
P/E Ratio12.9332.9439%
Revenue1.3B8.54B15%
Total Cash714M2.04B35%
Total Debt617M6.76B9%
FUNDAMENTALS RATINGS
LNTH vs ZTS: Fundamental Ratings
LNTH
ZTS
OUTLOOK RATING
1..100
6660
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
3979
SMR RATING
1..100
4019
PRICE GROWTH RATING
1..100
8962
P/E GROWTH RATING
1..100
3180
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (60) in the Medical Specialties industry is in the same range as ZTS (61) in the Pharmaceuticals Generic industry. This means that LNTH’s stock grew similarly to ZTS’s over the last 12 months.

LNTH's Profit vs Risk Rating (39) in the Medical Specialties industry is somewhat better than the same rating for ZTS (79) in the Pharmaceuticals Generic industry. This means that LNTH’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is in the same range as LNTH (40) in the Medical Specialties industry. This means that ZTS’s stock grew similarly to LNTH’s over the last 12 months.

ZTS's Price Growth Rating (62) in the Pharmaceuticals Generic industry is in the same range as LNTH (89) in the Medical Specialties industry. This means that ZTS’s stock grew similarly to LNTH’s over the last 12 months.

LNTH's P/E Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for ZTS (80) in the Pharmaceuticals Generic industry. This means that LNTH’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LNTHZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
54%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
57%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
59%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPLCX22.910.09
+0.39%
NYLI Epoch U.S. Equity Yield Class I
ETIMX14.840.05
+0.34%
Eventide Balanced Fund Class I
VPMAX183.460.30
+0.16%
Vanguard PRIMECAP Adm
HAINX54.11-0.14
-0.26%
Harbor International Institutional
GGWPX13.24-0.04
-0.30%
Goldman Sachs Global Infras P

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and MKKGY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and MKKGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+2.82%
MKKGY - LNTH
27%
Poorly correlated
-0.52%
DVAX - LNTH
24%
Poorly correlated
+1.79%
ZTS - LNTH
22%
Poorly correlated
-0.46%
TEVA - LNTH
22%
Poorly correlated
+1.29%
ACB - LNTH
21%
Poorly correlated
+0.62%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.46%
ELAN - ZTS
48%
Loosely correlated
+1.57%
VTRS - ZTS
44%
Loosely correlated
+0.64%
PAHC - ZTS
41%
Loosely correlated
-0.88%
AMRX - ZTS
39%
Loosely correlated
+0.75%
HLN - ZTS
37%
Loosely correlated
N/A
More